SCHEMBL361589

SCHEMBL361589

CC(C)C[C@H](O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185354 1.00
SCHEMBL28064758 1.00 RNPEP (0.52)
SCHEMBL1336542 1.00
SCHEMBL11476606 0.97 RNPEP (0.50)
SCHEMBL28300024 0.97 RNPEP (0.50)
Methane SCHEMBL11205299 0.97 RNPEP (0.50)
Hydrochloric Acid SCHEMBL3345131 0.97 RNPEP (0.50)
Lactic Acid SCHEMBL4626495 0.95 TP53 (0.58)
Leucine SCHEMBL20898433 0.86 SLC7A5 (0.78)
SCHEMBL30970939 0.84 TET2 (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119859167-A Preparation method of ISARIDIN E cyclic ester peptide 中山大学 2025-04-22 CN claimed
CN-118480474-B Lactobacillus paracasei with colon cancer cell apoptosis promoting effect and application thereof 四川大学 2025-03-18 CN claimed
CN-117285602-A Preparation method of depsipeptide natural product Isaridin A 哈尔滨工业大学(深圳) 2023-12-26 CN claimed
US-20220273690-A1 Edible Formulations Based on Active Ingredients and Arginine GRAAL S R L (IT) 2022-09-01 US claimed
EP-4021508-A1 FORMULATIONS COMPRISING ARGININE AND/OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND AN ACID ACTIVE INGREDIENT WITH A PKA OF 1 -5 Graal S.r.l. (IT) 2022-07-06 EP claimed
WO-2022121420-A1 ULTRAVIOLET STERILIZATION SYNERGIST AND STERILIZATION METHOD USING SAME IN COMBINATION WITH ULTRAVIOLET 华南农业大学 2022-06-16 WO claimed
CN-112655708-A Ultraviolet sterilization synergist (S) -2-hydroxy-4-methyl valeric acid and application thereof 华南农业大学 2021-04-16 CN claimed
WO-2021038486-A1 FORMULATIONS COMPRISING ARGININE AND/OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND AN ACID ACTIVE INGREDIENT WITH A PKA OF 1 -5 GRAAL S.R.L. (IT) 2021-03-04 WO claimed
CN-107299072-A Engineering bacterium and application thereof 江南大学 2017-10-27 CN claimed
EP-3197437-A1 COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF DIABETES AND/OR HYPERLIPIDEMIA NuSirt Sciences, Inc. (US) 2017-08-02 EP claimed
WO-2016049236-A1 COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF DIABETES AND/OR HYPERLIPIDEMIA NUSIRT SCIENCES, INC. (US) 2016-03-31 WO claimed
US-20100009966-A1 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2010-01-14 US claimed
EP-1811985-A1 NUTRIENT SUPPLEMENT AND USE OF THE SAME OY ELMOMED LTD (FI) 2007-08-01 EP claimed
EP-1326993-B1 PRODUCTION OF ALPHA-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM EXCELSYN MOLECULAR DEV LTD (GB) 2007-05-23 EP claimed
WO-2006042909-A1 NUTRIENT SUPPLEMENT AND USE OF THE SAME OY ELMOMED LTD (FI) 2006-04-27 WO claimed
US-20040053382-A1 Production of alpha-hydroxy-carboxylic acids using a coupled enzyme system EXCELSYN MOLECULAR DEVELOPMENT LIMITED (GB) 2004-03-18 US claimed
EP-1326993-A2 PRODUCTION OF g(a)-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM PCBU Services, Inc. (US) 2003-07-16 EP claimed
US-6458781-B1 BLOCKERS CALCIUM CHANNEL ANTAGONISTS FOR STROKES, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2002-10-01 US claimed
WO-2002033110-A2 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM PCBU SERVICES, INC. (US) 2002-04-25 WO claimed
WO-1999055688-A1 SUBSTITUTED DIARYLALKYL AMIDES AS CALCIUM CHANNEL ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1999-11-04 WO claimed